Search results for "S1"

showing 10 items of 755 documents

Naringenin Nano-Delivery Systems and Their Therapeutic Applications

2021

Naringenin (NRG) is a polyphenolic phytochemical belonging to the class of flavanones and is widely distributed in citrus fruits and some other fruits such as bergamot, tomatoes, cocoa, and cherries. NRG presents several interesting pharmacological properties, such as anti-cancer, anti-oxidant, and anti-inflammatory activities. However, the therapeutic potential of NRG is hampered due to its hydrophobic nature, which leads to poor bioavailability. Here, we review a wide range of nanocarriers that have been used as delivery systems for NRG, including polymeric nanoparticles, micelles, liposomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), nanosuspensions, and nano…

Naringeninnatural productsnaringeninlcsh:RS1-441Pharmaceutical ScienceReview02 engineering and technologyPharmacologylcsh:Pharmacy and materia medica03 medical and health scienceschemistry.chemical_compound0302 clinical medicineNutraceuticalSolid lipid nanoparticleflavonoidnutraceuticalsLiposomeChemistryfood and beverages021001 nanoscience & nanotechnologynanomedicineBioavailabilityantioxidants030220 oncology & carcinogenesisdrug deliveryDrug deliveryNanomedicinenanoparticlesNanocarriersbioavailability0210 nano-technologyPharmaceutics
researchProduct

Adaptative air traffic network: Statistical regularities in air traffic management

2016

Starting from traffic data on flights trajectories-planned and actual ones-in Europe, we build a navigation point network. We study this network which exhibits different features for different European countries. In particular, some countries uses a high number of navpoints, facilitating the planning of the flight plan by air companies at the cost of higher concentrations of traffic in few nodes. Making use of the deviations from the planned trajectories, we find that once again different countries have different control procedures with respect to traffic management. Interestingly, we find that some countries tend to make more deviations when the traffic conditions are low. Moreover, they t…

Navigation point networkControl and Systems EngineeringTraffic flow managementCommunicationNetwork scienceGeography Planning and DevelopmentAerospace EngineeringComputer Science Applications1707 Computer Vision and Pattern RecognitionTransportationStatistical modelSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)
researchProduct

Extracellular Vesicle-Mediated Cell–Cell Communication in the Nervous System: Focus on Neurological Diseases

2019

Extracellular vesicles (EVs), including exosomes, are membranous particles released by cells into the extracellular space. They are involved in cell differentiation, tissue homeostasis, and organ remodelling in virtually all tissues, including the central nervous system (CNS). They are secreted by a range of cell types and via blood reaching other cells whose functioning they can modify because they transport and deliver active molecules, such as proteins of various types and functions, lipids, DNA, and miRNAs. Since they are relatively easy to isolate, exosomes can be characterized, and their composition elucidated and manipulated by bioengineering techniques. Consequently, exosomes appear…

Nervous systemReviewCell CommunicationTheranostic NanomedicineCatalysilcsh:Chemistry0302 clinical medicineCell–cell interactionlcsh:QH301-705.5Tissue homeostasisSpectroscopyDrug Carriers0303 health sciencesnervous systemCell DifferentiationNeurodegenerative DiseasesComputer Science Applications1707 Computer Vision and Pattern RecognitionGeneral MedicineExtracellular vesicleComputer Science ApplicationsCell biologymedicine.anatomical_structureTheranostics toolExtracellular vesicleextracellular vesiclesneurological diseasesCell signalingCell typecell–cell interactionexosomesBiologyCatalysisInorganic Chemistry03 medical and health sciencesExtracellularmedicineCell-cell interactionHumansPhysical and Theoretical ChemistryMolecular Biology030304 developmental biologytheranostics toolsOrganic ChemistrybiomarkersBiomarkercentral nervous systemMicrovesiclesExosomelcsh:Biology (General)lcsh:QD1-999030217 neurology & neurosurgeryNeurological diseaseInternational Journal of Molecular Sciences
researchProduct

NG2-expressing cells in the nervous system revealed by the NG2-EYFP-knockin mouse.

2008

The NG2 glycoprotein is a type I membrane protein expressed by immature cells in the developing and adult mouse. NG2+ cells of the embryonic and adult brain have been principally viewed as oligodendrocyte precursor cells but have additionally been considered a fourth glial class. They are likely to be a heterogeneous population. In order to facilitate studies on the function of NG2+ cells and to characterize these cells in situ, we generated an enhanced yellow fluorescent protein (EYFP) “knockin mouse.” EYFP-expressing cells in heterozygous knockin mice expressed the NG2 protein in all regions and at all ages studied. The EYFP+ cells did not express markers of mature glia, developing or mat…

Nervous systemYellow fluorescent proteinTransgenePopulationHippocampusS100 Calcium Binding Protein beta SubunitHippocampusNervous SystemMiceEndocrinologyBacterial ProteinsGlutamate-Ammonia LigaseGeneticsmedicineAnimalsGene Knock-In TechniquesNerve Growth FactorsAntigenseducationPromoter Regions GeneticCells CulturedNeuronseducation.field_of_studyMicrogliabiologyS100 ProteinsBrainGene Expression Regulation DevelopmentalCell BiologyEmbryonic stem cellCell biologyLuminescent ProteinsOligodendrogliamedicine.anatomical_structurenervous systemMembrane proteinAstrocytesImmunologybiology.proteinProteoglycansMicrogliaGenesis (New York, N.Y. : 2000)
researchProduct

Non-cooperative game theory based stepwise power tariff model using Monte-Carle simulation for agricultural consumers

2019

Abstract In the present study the concept of non-cooperative game theory is proposed in the retail electricity market for introducing stepwise power tariff model (SPT) for agricultural consumers. The objective of the paper is to increase the energy generation through green energy generation sources (GEGS), introduction of plug-in hybrid electric vehicles, education of families, standard wiring and appliance efficiency in tariffs for agricultural consumers with non-cooperative game theory. Agricultural consumers are able to generate a huge amount of electricity through GEGS and are able to control the consumption in their own way, and the non-cooperative game theory is introduced. Energy con…

Non-cooperative gameretail electricity marketComputer sciencebusiness.industryS020209 energyAgriculture (General)020208 electrical & electronic engineeringTariffAgriculture02 engineering and technologyplug-in hybrid electric vehiclesnon-cooperative game theoryPower (physics)Theory basedS1-972MicroeconomicsAgriculturegreen energy generation sources0202 electrical engineering electronic engineering information engineeringGeneral Agricultural and Biological Sciencesbusinessstepwise power tariff modelOpen Agriculture
researchProduct

Polymorphisms in DCDC2 and S100B associate with developmental dyslexia

2015

Genetic studies of complex traits have become increasingly successful as progress is made in next-generation sequencing. We aimed at discovering single nucleotide variation present in known and new candidate genes for developmental dyslexia: CYP19A1, DCDC2, DIP2A, DYX1C1, GCFC2 (also known as C2orf3), KIAA0319, MRPL19, PCNT, PRMT2, ROBO1 and S100B. We used next-generation sequencing to identify single-nucleotide polymorphisms in the exons of these 11 genes in pools of 100 DNA samples of Finnish individuals with developmental dyslexia. Subsequent individual genotyping of those 100 individuals, and additional cases and controls from the Finnish and German populations, validated 92 out of 111 …

Nonsynonymous substitutionCandidate genemedicine.medical_specialtyShort CommunicationGenomicsS100 Calcium Binding Protein beta SubunitBiologyPolymorphism Single NucleotideDyslexia03 medical and health sciences0302 clinical medicineDCDC2Molecular geneticssingle-nucleotide polymorphismsmedicineHumansGenetic Predisposition to DiseasegeneticsGenotypingGenetic Association StudiesGenetics (clinical)ta515030304 developmental biologyGenetics0303 health sciencesperinnöllisyystiedeta1184DyslexiaSequence Analysis DNAmedicine.diseasedevelopmental dyslexiata3124Genetic epidemiologyCase-Control Studiesindividual genotypingMicrotubule-Associated Proteins030217 neurology & neurosurgeryJournal of Human Genetics
researchProduct

How to standardize (if you must)

2017

In many situations we are interested in appraising the value of a certain characteristic for a given individual relative to the context in which this value is observed. In recent years this problem has become prominent in the evaluation of scientific productivity and impact. A popular approach to such relative valuations consists in using percentile ranks. This is a purely ordinal method that may sometimes lead to counterintuitive appraisals, in that it discards all information about the distance between the raw values within a given context. By contrast, this information is partly preserved by using standardization, i.e., by transforming the absolute values in such a way that, within the s…

Normalization (statistics)z-scoreLocation statisticsStandardizationMonotonic functionLibrary and Information Sciences050905 science studiesSocial Sciences (all)NOPercentile rankCitation analysisEconometricsMathematicsCitation analysis; Dispersion statistics; Location statistics; m-score; Normalization; Standardization; z-score; Social Sciences (all); Computer Science Applications1707 Computer Vision and Pattern Recognition; Library and Information Sciences05 social sciencesCounterintuitiveGeneral Social SciencesLocation statisticDispersion statisticsComputer Science Applications1707 Computer Vision and Pattern RecognitionStandardizationComputer Science Applicationsm-scoreNormalizationConceptual frameworkCitation analysisCitation analysiNormative0509 other social sciences050904 information & library sciencesDispersion statistic
researchProduct

Characterization of somatostatin- and cholecystokinin-immunoreactive periglomerular cells in the rat olfactory bulb.

2005

Periglomerular cells (PG) are interneurons of the olfactory bulb (OB) that modulate the first synaptic relay of the olfactory information from the olfactory nerve to the dendrites of the bulbar principal cells. Previous investigations have pointed to the heterogeneity of these interneurons and have demonstrated the presence of two different types of PG. In the rat OB, type 1 PG receive synaptic contacts from the olfactory axons and are γ-aminobutyric acid (GABA)-ergic, whereas type 2 PG do not receive synaptic contacts from the olfactory axons and are GABA immunonegative. In this study, we analyze and characterize neurochemically a group of PG that has not been previously classified either …

Olfactory systemCalbindinsNeuropilOlfactory NervePresynaptic TerminalsSynaptic MembranesNeuropeptideOlfactionBiologyCalbindinSynaptic TransmissionS100 Calcium Binding Protein GOlfactory nerveMicroscopy Electron TransmissionInterneuronsNeural PathwaysNeuropilmedicineAnimalsRats Wistargamma-Aminobutyric AcidGeneral NeuroscienceNeural InhibitionImmunohistochemistryOlfactory BulbOlfactory bulbRatsSmellmedicine.anatomical_structurenervous systemFemaleCalretininCholecystokininSomatostatinNeuroscienceThe Journal of comparative neurology
researchProduct

Semi-Mechanistic Pharmacokinetic Model to Guide the Dose Selection of Nimotuzumab in Patients with Autosomal Dominant Polycystic Kidney Disease

2020

Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disease characterized by an overexpression of epidermal growth factor receptor (EGFR). Nimotuzumab is a recombinant humanized monoclonal antibody against human EGFR. The aim of this study was to develop a population pharmacokinetic model for nimotuzumab and to identify demographic and clinical predictive factors of the pharmacokinetic variability. The population pharmacokinetics (PopPK) of nimotuzumab was characterized using a nonlinear mixed-effect modeling approach with NONMEM&reg

Oncologymedicine.medical_specialtyEGFRPopulationAutosomal dominant polycystic kidney diseasePharmaceutical SciencePhases of clinical researchlcsh:RS1-441030226 pharmacology & pharmacyArticlesemi-mechanistic pharmacokineticslcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicinePharmacokineticsInternal medicinepopulation analysismedicinePolycystic kidney diseaseNimotuzumabEpidermal growth factor receptoreducationNONMEMeducation.field_of_studybiologyautosomal dominant polycystic kidney diseasebusiness.industrynimotuzumabmedicine.diseaseNONMEM030220 oncology & carcinogenesisbiology.proteinbusinessmedicine.drugPharmaceutics
researchProduct

Population Pharmacokinetics of Palbociclib in aReal-World Situation

2021

Palbociclib is an oral cyclin-dependent kinase inhibitor that is used in combination with aromatase inhibitors in the treatment of postmenopausal women with metastatic breast cancer. Its metabolism profile is associated with an important interpatient variability. We performed a population pharmacokinetics study of palbociclib in women routinely followed in a cancer center. One hundred and fifty-one samples were analyzed. The sampling times after administration ranged from 0.9 to 75 h and the samples were taken between 1 and 21 days after the beginning of the palbociclib cycle. Palbociclib was determined using a validated mass spectrometry method. The best model that described the concentrat…

Oncologymedicine.medical_specialtypalbociclibPharmaceutical ScienceRenal functionlcsh:Medicinelcsh:RS1-441Population pharmacokineticsAbsorption (skin)Palbociclib030226 pharmacology & pharmacyArticlelcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicineLag timepopulation pharmacokineticsInternal medicineDrug Discoverymedicinereal-world situationDosingPostmenopausal womenbusiness.industrylcsh:Rmedicine.diseaseMetastatic breast cancer030220 oncology & carcinogenesisMolecular MedicinebusinessPharmaceuticals
researchProduct